Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Androstenes
  • Biomarkers, Tumor
  • Neoplastic Cells, Circulating
  • Prostatic Neoplasms, Castration-Resistant

abstract

  • A biomarker panel containing CTC number and LDH level was shown to be a surrogate for survival at the individual-patient level in this trial of abiraterone acetate plus prednisone versus prednisone alone for patients with metastatic CRPC. Additional trials are ongoing to validate the findings.

publication date

  • April 20, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4397279

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.55.3487

PubMed ID

  • 25800753

Additional Document Info

start page

  • 1348

end page

  • 55

volume

  • 33

number

  • 12